Fact CheckerSign in

NCT07469280Not yet recruiting

High-Intensity Progressive Inspiratory Muscle Training in Class III Obesity and Obstructive Sleep Apnea

High-Intensity Progressive Inspiratory Muscle Training in Class III Obesity and Obstructive Sleep Apnea: Study Protocol for a Prospective Nonconcurrent Multiple-Baseline Single-Case Experimental Design With Stability-Based Phase Transition

Source: ClinicalTrials.gov · Last updated 23 Mar 2026

Brief summary (registry, in English)

The purpose of this study is to evaluate the feasibility and effects of a 12-week high-intensity progressive Inspiratory Muscle Training (IMT) program in individuals with Class III obesity (BMI ≥ 40 kg/m²) and obstructive sleep apnea (OSA). Using a single-case experimental design (SCED) with multiple baselines, the study will investigate whether this respiratory intervention can reduce the severity of sleep apnea, as measured by the Apnea-Hypopnea Index (AHI), and improve inspiratory muscle strength and sleep quality. Participants will perform daily training sessions using a resistive loading device (POWERbreathe), with intensity progressing from 40% to 90% of their maximum inspiratory pressure.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
10 (estimated)
First submitted
9 Mar 2026
Start date
1 May 2026
Primary completion date
1 May 2027
Lead sponsor
University of the State of Santa Catarina
Diseases
Obesity
NCT number
NCT07469280

What you commit to

  • Study type: Interventional
  • Planned participants: 10
  • From 1 May 2026 to the primary completion date, 1 May 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Are using medications that may affect muscle performance.
  • Are currently using CPAP therapy.

Other illness

  • Systemic diseases (pulmonary, cardiac or renal).
  • Conditions that could compromise adherence to the study protocol.

Who the study is looking for

  • Of both genders.
  • Class III obesity (BMI \> 40 kg/m²).
  • Diagnosis of OSA.
  • Without neurological conditions that would prevent them from responding to the study assessments.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Santa Catarina State University - CEFID (Center of Health and Sport Sciences)
Coordinator of this site? Confirm its status
FlorianópolisBrazilUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.